Jazz Pharmaceuticals plc
JAZZ· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $291.23M | $208.25M | $124.23M | $64.57M |
| Net Income | $43.66M | $42.19M | $27.15M | $33.20M |
| EPS Diluted | $0.70 |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| $0.69 |
| $0.45 |
| $0.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.